FHYSX Fees and Costs — Federated Hermes High Yield Strategy Portfolio
Data updated: 2026-08-25
The net expense ratio is 0.04% (0.38% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 33%.
FHYSX Fees and Expenses
Annual operating expenses and sales charges of FHYSX. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.00% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.34% |
| Gross expense ratio | 0.38% |
| Fee waiver | −0.34% |
| Net expense ratio | 0.04% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | 0.00% |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
FHYSX Costs Over Time
On $10,000 invested in FHYSX, assuming 5% a year before costs, total costs come to $26 over 5 years, cutting the return by 0.04% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.04%) | $4 | $13 | $23 |
| Lost growth on money paid in costs | $0 | $1 | $2 |
| Total costs | $4 | $14 | $26 |
| Value after costs | $10,496 | $11,562 | $12,737 |
| Impact on return, per year | 0.04% | 0.04% | 0.04% |
FHYSX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): $261.2M
- Portfolio turnover (prospectus): 33%
- Securities lending: none during the year
FHYSX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BofA Securities, Inc. | $163.2M | 62.47% |
| Federated Securities Corp. | $87.7M | 33.58% |
| BMO Capital Markets Corp. | $9.7M | 3.70% |
| Barclays Capital Inc. | $656K | 0.25% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.